cbdMD (YCBD) Current Accrued Expense: $0.59 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YCBD cbdMD Inc YCBD
37 GF Score
Price $0.48
GF Value $0.16
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is cbdMD Current Accrued Expense?

cbdMD YCBD -1.12% 37 Current Accrued Expense is $0.59 Mil as of Jun. 2026. GuruFocus rates YCBD with a GF Score™ of 37/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 3 warning signs investors should review.

cbdMD's Current Accrued Expense for the quarter that ended in Jun. 2026 was $0.59 Mil.

cbdMD's quarterly Current Accrued Expense declined from Dec. 2025 ($0.81 Mil) to Mar. 2026 ($0.63 Mil) and declined from Mar. 2026 ($0.63 Mil) to Jun. 2026 ($0.59 Mil).

cbdMD's annual Current Accrued Expense stayed the same from Sep. 2023 ($0.63 Mil) to Sep. 2024 ($0.63 Mil) but then increased from Sep. 2024 ($0.63 Mil) to Sep. 2025 ($0.74 Mil).

cbdMD Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for cbdMD's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

cbdMD Current Accrued Expense Chart

cbdMD Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.73 2.06 0.63 0.63 0.74

cbdMD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 0.74 0.81 0.63 0.59
YCBD
37GF Score
cbdMD Inc YCBD
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

cbdMD Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.59 Mil mean?
cbdMD (YCBD) has a Current Accrued Expense of $0.59 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on cbdMD and its competitors.
Is cbdMD's Current Accrued Expense too high?
cbdMD's current Current Accrued Expense is $0.59 Mil. Overall, cbdMD has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's Current Accrued Expense compare to BTAI and LVRLF?
cbdMD's Current Accrued Expense of $0.59 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on cbdMD and its competitors. cbdMD's current Current Accrued Expense is $0.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.48 — trading 197.3% above its estimated fair value. The current Current Accrued Expense is $0.59 Mil. cbdMD's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For cbdMD (YCBD), the current Current Accrued Expense is $0.59 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is cbdMD (YCBD) Overvalued in 2026?

Based on GuruFocus' analysis, cbdMD stock appears to be overvalued. The current stock price of $0.48 is trading 197.3% above its estimated GF Value™ of $0.16. GuruFocus considers cbdMD to be Significantly Overvalued.

Key valuation signals for YCBD:

  • Current Accrued Expense: $0.59 Mil
  • GF Value™: $0.16 vs. price of $0.48 (197.3% above fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

cbdMD Business Description

Address 2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
37GF Score

Get the complete analysis for YCBD

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price
$0.16
GF Value